Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 50 years old, of any sex, who have been diagnosed with multiple sclerosis (MS) according to a specific set of recognised diagnostic guidelines (the 2017 revised McDonald's Criteria), including any form of MS such as relapsing-remitting, primary progressive, or secondary progressive, and who are already attending follow-up appointments at an MS clinic.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had an MS relapse recently, or who have taken corticosteroid medications in the past 3 months.
- People who have another serious health condition such as diabetes, high blood pressure, heart disease, liver disease, kidney disease, or a history of heavy alcohol use.
- People who follow a specific or restrictive diet.
- People who are currently taking anti-inflammatory drugs, cholesterol-lowering medications, hormone replacement therapy (oestrogen), steroid treatments, or any other medications that could affect how the body processes nutrients or metabolism.
- People who have a demyelinating condition that is not MS, such as NMOSD (Neuromyelitis Optica Spectrum Disorder) or MOGAD (MOG Antibody-Associated Disease).
- People who are unlikely to attend follow-up appointments consistently throughout the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
prevalence of insulin resistance among Egyptians with multiple sclerosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.